Profile

Prior to joining the Radcliffe Group in November 1999, Dr. Gale worked as an Applications Consultant for Amersham Pharmacia Biotech.
While at Amersham Pharmacia Biotech, he provided business and product development support and training for automated DNA sequencing and fragment analysis products and applications.
Prior to that, he performed drug discovery research at DuPont Merck Pharmaceutical Company in the Cancer Molecular Biology Division and at SmithKline Beecham Corporation in the Drug Metabolism Department.
Dr. Gale received his Ph.D.
in Biochemistry from Vanderbilt University School of Medicine in 1992, his M.B.A in Investment Management and Management Information Systems from the LeBow College of Business at Drexel University in 1999, and his B.S.
in Toxicology, magna cum laude, from the University of the Sciences in Philadelphia in 1986.
He is a CFA Charterholder, as well as a member of both the CFA Institute and the Financial Analysts Society of Philadelphia.

Former positions of Kevin Gale

CompaniesPositionEnd
Analyst-Equity 27/02/2009
See the detail of Kevin Gale's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kevin Gale's experience

Connections

7

1st degree connections

1

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies1

Finance

See company connections